HSBC Life launches critical illness plans - CIExpert analysis

Only available via UnderwriteMe

Adam Saville
clock
Alan Lakey, director, CIExpert
Image:

Alan Lakey, director, CIExpert

'Solid plan offering a wide range of conditions' but HSBC will need to 'work hard to convince advisers'

After entering the advised space with a life assurance proposition last year, HSBC Life has followed it with the launch of two critical illness products - critical illness and critical illness plus - both only accessible to advisers via UnderwriteMe. Each are available as a standalone plan or with integrated life insurance. CIExpert director Alan Lakey said the model follows the trend started by Aviva "where a lower cost basic plan runs alongside a more expensive and more comprehensive version"....

To continue reading this article...

Join Cover

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Exclusive access to our fortnightly Protection insight mini-podcast.
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Jo Throp: Neurological conditions require a specialist approach

Jo Throp: Neurological conditions require a specialist approach

"The protection industry needs to consider more deeply the cost and impact of neurological claims"

John Brazier
clock 18 January 2022 • 8 min read
Royal London extends Helping Hand wellbeing services

Royal London extends Helping Hand wellbeing services

Includes GP consultations and mental wellbeing app

John Brazier
clock 17 January 2022 • 1 min read
Aviva's DigiCare+ records high cholesterol levels and poor liver health

Aviva's DigiCare+ records high cholesterol levels and poor liver health

Among individual and group protection clients

John Brazier
clock 17 January 2022 • 2 min read